Foxp3+ Tregs are the major constituent of the TILs in claudin-low TNBC tumors and it has been speculated that the recruitment of Foxp3+ Tregs to the TME inhibits an effective anti-tumor immune response of checkpoint inhibitors [50]. The gene discussed is FOXP3; the disease is neoplasm.